
An interprofessional faculty of gastroenterology clinicians discuss real-world issues in managing patients with primary biliary cholangitis. Two mini-lectures serve as the foundation for understanding the diagnostic evaluation and risk factors of primary biliary cholangitis. Three cases foster a robust discussion, among the 5 faculty, of clinical decision-making around the roles, benefits, and limitations of approved and investigational pharmacologic treatment options. The program format fosters critical thinking and application of material to patient cases, allowing participants to benefit from the insights provided by the faculty.
The lectures are also available as a podcast: You may listen here
Course Credit:
1 AAPA Category I Hour
1 ACPE Contact Hour
1 AMA PRA Category 1 CreditTM
1 ANCC Contact Hour
1 CA-BRN Contact Hour
1 Pharmacology Hour
Dates:
Opens: 2023-09-30
Closes: 2024-09-30
Target Audience:
This activity was developed for gastroenterologists, hepatologists, primary care physicians, nurse practitioners, physician assistants/associates, and pharmacists who have a role in the diagnosis, management, and monitoring of patients with primary biliary cholangitis (PBC).
This activity is supported by an educational grant from Intercept.
Accreditation

The Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Annenberg Center for Health Sciences at Eisenhower designates this knowledge-based activity for a maximum of 1 hour . Credit will be provided to NABP CPE Monitor within 60 days after the activity completion.

Annenberg Center for Health Sciences at Eisenhower designates this enduring activity for a maximum of 1 contact hour, including 1 pharmacology hour.
To receive credit for education contact hours outside of the state of California, please check with your state board of registered nursing for reciprocity.

Additional Content Planners
Heather Jimenez, MSN, FNP-C (Nurse Planner)No significant relationships to disclose.
Kam A. Newman, MD (Peer Reviewer)
No significant relationships to disclose.
Michael Smith, PharmD, BCPS (Medical Writer)
Consultant: Wolters-Kluwer
Annenberg Center for Health Sciences
Staff at the Annenberg Center for Health Sciences at Eisenhower have no relevant financial relationships to disclose.
All of the financial relationships listed for these individuals have been mitigated.
-
Shubha Bhat, PharmD, MS, BCACP
Clinical Pharmacy Specialist - Gastroenterology
Digestive Disease & Surgery Institute
Cleveland Clinic
Cleveland, Ohio -
James Boyer, MD
Ensign Professor of Medicine (Digestive Diseases)
Yale University School of Medicine
New Haven, Connecticut -
Sarah Enslin, PA-C
APP Manager, Medicine Service Line
Lead APP, Gastroenterology and Hepatology
University of Rochester Medical Center
Rochester, New York -
Donald Gardenier, DNP, FNP-C
Nurse Practitioner, Gastroenterology
-
Seth N. Sclair, MD
Associate Professor of Medicine
Case Western Reserve University School of Medicine
Division of Gastroenterology and Liver Disease
Medical Director, Liver Transplant Program
University Hospitals Cleveland Medical Center
Digestive Health Institute
Cleveland, Ohio
Presenting Faculty
Downloads
Learning Objectives
- Identify appropriate tests and support decision-making in the diagnosis of primary biliary cholangitis (PBC)
- Engage in best practices in the use of ursodiol as initial therapy for PBC, including monitoring response to therapy
- Incorporate obeticholic acid into routine care for patients with PBC who do not respond to or are intolerant of ursodiol
- Demonstrate an understanding of the importance and role of the interprofessional care team
Faculty Disclosures
Shubha Bhat, PharmD, MS, BCACP
Advisory Board: Boehringer Ingelheim, Bristol Myers Squibb, Pfizer, Pharmacosmos
Consultant: AbbVie
Speakers Bureau: Eli Lilly, Prometheus Laboratory
James Boyer, MD
No relationships to disclose.Sarah Enslin, PA-C
Advisory Board: Castle Biosciences, Exact Sciences, Regeneron Pharmaceuticals
Donald Gardenier, DNP, FNP-C
No relationships to disclose.Seth N. Sclair, MD
Speakers Bureau: Mallinckrodt